Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth.

Placencio VR, Li X, Sherrill TP, Fritz G, Bhowmick NA.

PLoS One. 2010 Sep 23;5(9):e12920. doi: 10.1371/journal.pone.0012920.

2.

Homeostatic competition drives tumor growth and metastasis nucleation.

Basan M, Risler T, Joanny JF, Sastre-Garau X, Prost J.

HFSP J. 2009 Aug;3(4):265-72. doi: 10.2976/1.3086732. Epub 2009 Mar 20.

3.

Pathology of prostate cancer and focal therapy ('male lumpectomy').

Mazzucchelli R, Scarpelli M, Cheng L, Lopez-Beltran A, Galosi AB, Kirkali Z, Montironi R.

Anticancer Res. 2009 Dec;29(12):5155-61. Review.

4.

IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis.

McCandless EE, Budde M, Lees JR, Dorsey D, Lyng E, Klein RS.

J Immunol. 2009 Jul 1;183(1):613-20. doi: 10.4049/jimmunol.0802258. Epub 2009 Jun 17.

5.

Evidence for field cancerization of the prostate.

Nonn L, Ananthanarayanan V, Gann PH.

Prostate. 2009 Sep 15;69(13):1470-9. doi: 10.1002/pros.20983. Review.

6.

Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts.

Zhao H, Peehl DM.

Prostate. 2009 Jun 15;69(9):991-1000. doi: 10.1002/pros.20946.

7.

Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis.

Li X, Placencio V, Iturregui JM, Uwamariya C, Sharif-Afshar AR, Koyama T, Hayward SW, Bhowmick NA.

Oncogene. 2008 Nov 27;27(56):7118-30. doi: 10.1038/onc.2008.293. Epub 2008 Aug 25.

8.

Genetic and microenvironmental implications in prostate cancer progression and metastasis.

Alberti C.

Eur Rev Med Pharmacol Sci. 2008 May-Jun;12(3):167-75. Review.

PMID:
18700688
9.

Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.

Placencio VR, Sharif-Afshar AR, Li X, Huang H, Uwamariya C, Neilson EG, Shen MM, Matusik RJ, Hayward SW, Bhowmick NA.

Cancer Res. 2008 Jun 15;68(12):4709-18. doi: 10.1158/0008-5472.CAN-07-6289.

10.

Multi-faceted roles for CXC-chemokines in prostate cancer progression.

Waugh DJ, Wilson C, Seaton A, Maxwell PJ.

Front Biosci. 2008 May 1;13:4595-604. Review.

PMID:
18508531
11.

Gene targeting to the stroma of the prostate and bone.

Jackson RS 2nd, Franco OE, Bhowmick NA.

Differentiation. 2008 Jul;76(6):606-23. doi: 10.1111/j.1432-0436.2008.00273.x. Epub 2008 May 20. Review.

12.

Wnt signalling and its impact on development and cancer.

Klaus A, Birchmeier W.

Nat Rev Cancer. 2008 May;8(5):387-98. doi: 10.1038/nrc2389.

PMID:
18432252
13.

Regulation of HGF and SDF-1 expression by oral fibroblasts--implications for invasion of oral cancer.

Daly AJ, McIlreavey L, Irwin CR.

Oral Oncol. 2008 Jul;44(7):646-51. Epub 2007 Nov 9.

PMID:
17996483
15.

Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.

Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW.

Cancer Res. 2007 May 1;67(9):4244-53.

16.
17.

Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis.

Hill R, Song Y, Cardiff RD, Van Dyke T.

Cell. 2005 Dec 16;123(6):1001-11.

18.

A multiscale model for avascular tumor growth.

Jiang Y, Pjesivac-Grbovic J, Cantrell C, Freyer JP.

Biophys J. 2005 Dec;89(6):3884-94. Epub 2005 Sep 30. Erratum in: Biophys J. 2006 Jul 15;91(2):775.

19.

Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.

Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, Arteaga CL, Neilson EG, Hayward SW, Moses HL.

Oncogene. 2005 Jul 28;24(32):5053-68.

20.

Functional characterization of SDF-1 proximal promoter.

García-Moruja C, Alonso-Lobo JM, Rueda P, Torres C, González N, Bermejo M, Luque F, Arenzana-Seisdedos F, Alcamí J, Caruz A.

J Mol Biol. 2005 Apr 22;348(1):43-62.

PMID:
15808852
Items per page

Supplemental Content

Write to the Help Desk